Exane Asset Management’s Braskem BAK Stock Holding History

Exane Asset Management’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-329,405	Closed	-$8.65M	–	128
2017 Q4	$8.65M	Buy	+329,405	New	+$9.41M	2.69%	14

Other funds holding BAK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Asset Management's BAK Position: Q1 2018 in Review

Exane Asset Management sold out of Braskem (BAK) in Q1 2018, closing a stake of 329,405 shares — an estimated $8.65M sold.

Exane Asset Management first reported a position in BAK in Q4 2017 and held it in 1 quarter. The position peaked at $8.65M in Q4 2017. 104 funds tracked by Wall St. Rank hold BAK as of Q1 2018.

Exane Asset Management reported no remaining Braskem position as of Q1 2018 after selling out during the quarter.
Exane Asset Management sold 329,405 Braskem shares in Q1 2018, an estimated $8.65M.
Exane Asset Management first reported a position in Braskem in Q4 2017 and held it in 1 quarter.
Exane Asset Management's Braskem position peaked at $8.65M in Q4 2017.
104 funds tracked by Wall St. Rank held Braskem as of Q1 2018.

Based on Exane Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.